Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19
- PMID: 32532933
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19
Abstract
Since December 2019, the emergence of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection has been reported unexpectedly in Wuhan, China, with staggering infection speed across China and around the world. To date, seven known strains of HCoVs belonging to four genera (i.e., α?, β?, γ, and δ-CoV) have been recognized; the latest one has been identified as the SARS-CoV-2. Although the common transmission routes of SARS-CoV-2 is the respiratory tract, it seems that other routes such as the gastrointestinal tract may be effective for the entry of the virus in the body. Although there are no biological markers to predict the susceptibility of humans to COVID-19, several risk factors have been identified to predict the susceptibility of patients to COVID-19. Initial data revealed that males, pregnant women, elderly, and underlying conditions predispose patients to higher morbidity or mortality and also might be at risk for a severe infection of COVID-19. There is a greater need to better understand the mechanisms and risk factors of transmission routes. To date, despite the whole world effort to review various aspects of SARS-CoV-2, including epidemiology, clinical manifestations, diagnosis, and treatment options, there are still gaps in the knowledge of this disease and many issues remain unclear. Therefore, there is an urgent need for update data on SARS-CoV-2. Here, this study provide the current epidemiological status (transmission routes and risk of transmission, possible origins and source, mortality and morbidity risk, and geographical distribution) of the SARS-CoV-2 in the world in 2020.
Similar articles
-
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312. Biomolecules. 2020. PMID: 32933047 Free PMC article. Review.
-
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4. J Infect Public Health. 2020. PMID: 32778421 Free PMC article.
-
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16. OMICS. 2020. PMID: 32940573 Review.
-
The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.Eur J Med Res. 2020 Sep 4;25(1):39. doi: 10.1186/s40001-020-00439-w. Eur J Med Res. 2020. PMID: 32887660 Free PMC article.
-
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11. J Med Virol. 2020. PMID: 32104915 Free PMC article. Review.
Cited by
-
In Silico Analysis of Calotropis procera-Derived Phytochemicals Targeting 3CL Proteoase of SARS-CoV-2.Mol Biotechnol. 2024 Aug 23. doi: 10.1007/s12033-024-01253-z. Online ahead of print. Mol Biotechnol. 2024. PMID: 39177861
-
Host-Pathogen Interaction: Biology and Public Health.Methods Mol Biol. 2024;2751:3-18. doi: 10.1007/978-1-0716-3617-6_1. Methods Mol Biol. 2024. PMID: 38265706
-
Relationship between steroid use and superinfections in SARS-CoV-2 patients. A systematic review and meta-analysis.Infect Ecol Epidemiol. 2023 Nov 27;13(1):2277000. doi: 10.1080/20008686.2023.2277000. eCollection 2023. Infect Ecol Epidemiol. 2023. PMID: 38187166 Free PMC article. Review.
-
Polymerase chain reaction-positivity and predictors for SARS-CoV-2 infection among diagnosed cases' in North West Ethiopia.Health Sci Rep. 2023 Oct 26;6(10):e1663. doi: 10.1002/hsr2.1663. eCollection 2023 Oct. Health Sci Rep. 2023. PMID: 37900095 Free PMC article.
-
Analysis between ABO blood group and clinical outcomes in COVID-19 patients and the potential mediating role of ACE2.Front Med (Lausanne). 2023 Jun 23;10:1167452. doi: 10.3389/fmed.2023.1167452. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37425304 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous